Press Release: Hayward Holdings Reports Third Quarter Fiscal Year 2025 Financial Results and Increases 2025 Guidance

Dow Jones10-29

THIRD QUARTER FISCAL 2025 SUMMARY

   --  Net Sales increased 7% year-over-year to $244.3 million 
 
   --  Net Income increased 46% year-over-year to $24.0 million 
 
   --  Adjusted EBITDA* increased 16% year-over-year to $59.1 million 
 
   --  Diluted EPS increased 57% year-over-year to $0.11 
 
   --  Adjusted diluted EPS* increased 27% year-over-year to $0.14 
CHARLOTTE, N.C.--(BUSINESS WIRE)--October 29, 2025-- 

Hayward Holdings, Inc. (NYSE: HAYW) ("Hayward" or the "Company"), a global designer, manufacturer and marketer of a broad portfolio of pool and outdoor living technology, today announced financial results for the third quarter ended September 27, 2025 of its fiscal year 2025. Comparisons are to financial results for the prior-year third fiscal quarter.

CEO COMMENTS

"I am pleased to report third quarter results ahead of expectations, marking another quarter of strong execution by our global team", said Kevin Holleran, Hayward's President and Chief Executive Officer. "Our performance reflects the resiliency of our aftermarket model and continued traction in our strategic initiatives. Net sales increased 7% year-over-year with growth across both the North America and Europe and Rest of World segments. We delivered further solid margin expansion, driven by increased operational efficiencies, tariff mitigation actions, and disciplined cost management. Cash flow generation was robust, enabling us to further strengthen the balance sheet and reduce net leverage to 1.8x, the lowest level in over three years. As a result of our strong year-to-date performance and solid participation in our early buy programs, we are increasing our full year guidance. We remain focused on profitable growth and long-term shareholder value creation, and our investments in innovation, customer experience, and operational excellence are driving positive results."

THIRD QUARTER FISCAL 2025 CONSOLIDATED RESULTS

Net sales increased by 7% to $244.3 million for the third quarter of fiscal 2025. The increase in net sales during the quarter was driven by positive net price to offset inflation and tariffs, increased volume, and the favorable impact from foreign currency translation. The increase in volume was driven by the favorable timing of orders in the 2025 season.

Gross profit increased by 11% to $125.1 million for the third quarter of fiscal 2025. Gross profit margin increased 150 basis points to 51.2%. The increase in gross profit margin was due to positive net price impact, the absence of a non-cash increase to cost of goods sold resulting from the fair value inventory step-up adjustment recognized as part of the purchase accounting for the acquisition of ChlorKing HoldCo, LLC and related entities ("ChlorKing") recorded in the prior-year period, and operational efficiencies in our manufacturing facilities, partially offset by an increase in costs driven by tariffs and inflation.

Selling, general, and administrative expense ("SG&A") increased by 8% to $69.8 million for the third quarter of fiscal 2025. The increase in SG&A was primarily due to higher incentive compensation and higher salary costs driven by investments in our selling and customer care teams and wage inflation, and a non-recurring litigation expense, partially offset by decreased warranty costs. As a percentage of net sales, SG&A increased 30 basis points to 28.6%, compared to the prior-year period of 28.3%, driven by the factors discussed above. Research, development, and engineering expenses were $7.1 million for the third quarter of fiscal 2025, or 2.9% of net sales, as compared to $6.4 million for the prior-year period, or 2.8% of net sales.

Operating income increased by 23% to $41.1 million for the third quarter of fiscal 2025, due to the aggregated effects of the items described above. Operating income as a percentage of net sales ("operating margin") was 16.8% for the third quarter of fiscal 2025, a 210 basis point increase from the 14.7% operating margin in the prior-year period.

Interest expense, net, decreased by 14% to $11.3 million for the third quarter of fiscal 2025 driven by lower interest rates on the first lien term loan facility and increased interest income on cash deposits.

Income tax expense for the third quarter of fiscal 2025 was $7.2 million, resulting in an effective tax rate of 23.0%, compared to an income tax expense of $4.4 million, for an effective tax rate of 21.1%, for the prior-year period. The change in the effective tax rate was primarily due to a decrease in tax benefit from stock compensation.

Net income increased by 46% to $24.0 million for the third quarter of fiscal 2025. Net income margin expanded 250 basis points to 9.8%.

Adjusted EBITDA* increased by 16% to $59.1 million for the third quarter of fiscal 2025 from $51.1 million in the prior-year period. Adjusted EBITDA margin* expanded 170 basis points to 24.2%.

Diluted EPS increased by 57% to $0.11 for the third quarter of fiscal 2025. Adjusted diluted EPS* increased by 27.3% to $0.14 for the third quarter of fiscal 2025.

THIRD QUARTER FISCAL 2025 SEGMENT RESULTS

North America

Net sales increased by 7% to $208.2 million for the third quarter of fiscal 2025. The increase was driven by positive net price to offset inflation and tariffs and a modest increase in volume.

Segment income increased by 7% to $55.4 million for the third quarter of fiscal 2025. Adjusted segment income* increased by 4% to $61.7 million.

Europe & Rest of World

Net sales increased by 11% to $36.1 million for the third quarter of fiscal 2025. The increase was primarily due to the rise in volume and the favorable impact of foreign currency translation, partially offset by the impact of a decrease in net price. The increase in volume was driven by shipment timing under the early buy program.

Segment income increased by 152% to $6.2 million for the third quarter of fiscal 2025. Adjusted segment income* increased by 144% to $6.7 million.

BALANCE SHEET AND CASH FLOW

As of September 27, 2025, Hayward had cash and cash equivalents of $428.7 million, short-term investments of $19.7 million and approximately $104.1 million available for future borrowings under its revolving credit facilities. Cash flow provided by operations for the nine months ended September 27, 2025 of $283.0 million was an increase of $7.2 million from the prior-year period. The increase in cash provided was primarily driven by an increase in net income, partially offset by less cash generated by changes in working capital compared to the prior-year period.

OUTLOOK

Hayward is increasing its full year 2025 guidance. For fiscal year 2025, Hayward now expects net sales of $1.095 billion to $1.110 billion, or an increase of approximately 4% to 5.5% from fiscal year 2024, compared to our prior guidance of $1.070 billion to $1.100 billion. We now expect Adjusted EBITDA* of $292 million to $297 million, or an increase of approximately 5% to 7% from fiscal year 2024, compared to our prior guidance of $280 million to $290 million.

Hayward is excited about the long-term dynamics of the pool industry. The installed base of pools increases every year, providing continued growth opportunities, and the Company benefits from favorable secular demand trends in outdoor living, sunbelt migration, and technology adoption. Hayward continues to leverage its competitive advantages and drive increasing adoption of its leading SmartPad$(TM)$ pool equipment products both in new construction and the aftermarket, which represents approximately 85% of net sales. Hayward is confident in its long-term outlook for profitable growth and robust cash flow generation, driven by its technology leadership, operational excellence, strong brand and installed base, and multi-channel capabilities.

Please see the Forward-Looking Statements section of this release for a discussion of certain risks relevant to Hayward's outlook.

CONFERENCE CALL INFORMATION

Hayward will hold a conference call to discuss the results today, October 29, 2025 at 9:00 a.m. $(ET)$.

Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of the Company's website at https://investor.hayward.com/events-and-presentations/default.aspx. An earnings presentation will be posted to the Investor Relations section of the Company's website prior to the conference call.

The conference call can also be accessed by dialing (877) 423-9813 or (201) 689-8573.

For those unable to listen to the live conference call, a replay will be available approximately three hours after the call through the archived webcast on the Hayward website or by dialing (844) 512-2921 or (412) 317-6671. The access code for the replay is 13756418. The replay will be available until 11:59 p.m. Eastern Time on November 12, 2025.

ABOUT HAYWARD HOLDINGS, INC.

Hayward Holdings, Inc. (NYSE: HAYW) is a leading global designer and manufacturer of pool and outdoor living technology. With a mission to deliver exceptional products, outstanding service and innovative solutions to transform the experience of water, Hayward offers a full line of energy-efficient and sustainable residential and commercial pool equipment including pumps, heaters, sanitizers, filters, LED lighting, water features, and cleaners all digitally connected through Hayward's intuitive IoT-enabled SmartPad(TM).

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release contains certain statements that are "forward-looking statements" as that term is defined under the Private Securities Litigation Reform Act of 1995 (the "Act") and releases issued by the Securities and Exchange Commission (the "SEC"). Such forward-looking statements relating to Hayward are based on the beliefs of Hayward's management as well as assumptions made by, and information currently available to it. These forward-looking statements include, but are not limited to, statements about Hayward's strategies, plans, objectives, expectations, intentions, expenditures and assumptions and other statements contained in or incorporated by reference in this earnings release that are not historical facts. When used in this document, words such as "guidance," "outlook," "may," "will," "should," "could," "intend, " "potential," "continue," "anticipate," "believe," "estimate," "expect, " "plan," "target," "predict," "project," "seek" and similar expressions as they relate to Hayward are intended to identify forward-looking statements. Hayward believes that it is important to communicate its future expectations to its stockholders, and it therefore makes forward-looking statements in reliance upon the safe harbor provisions of the Act. However, there may be events in the future that Hayward is not able to accurately predict or control, and actual results may differ materially from the expectations it describes in its forward-looking statements.

Examples of forward-looking statements include, among others, statements Hayward makes regarding: Hayward's 2025 guidance and outlook; business plans and objectives; general economic and industry trends; business prospects; future product development and acquisition strategies; future channel stocking levels; growth and expansion opportunities; operating results; and working capital and liquidity. The forward-looking statements in this earnings release are only predictions. Hayward may not achieve the plans, intentions or expectations disclosed in Hayward's forward-looking statements, and you should not place significant reliance on its forward-looking statements. Hayward has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its business, financial condition and results of operations. Moreover, neither Hayward nor any other person assumes responsibility for the accuracy and completeness of forward-looking statements taken from third-party industry and market reports.

Important factors that could affect Hayward's future results and could cause those results or other outcomes to differ materially from those indicated in its forward-looking statements include the following: its relationships with and the performance of distributors, builders, buying groups, retailers and servicers who sell Hayward's products to pool owners; the impact of changes in laws, regulations and administrative policy, including those that limit U.S. tax benefits, impact trade agreements, or address the impacts of climate change; impacts on Hayward's business from the sensitivity of its business to seasonality and unfavorable economic business conditions; Hayward's ability to develop, manufacture and effectively and profitably market and sell its new planned and future products; the impact of product manufacturing disruptions, including as a result of catastrophic and other events beyond Hayward's control; competition from national and global companies, as well as lower-cost manufacturers; the imposition, or threat of imposition, of tariffs and other trade restrictions could adversely affect Hayward's business, including as a result of an adverse impact on general economic conditions; its ability to execute on its growth strategies and expansion opportunities; Hayward's exposure to credit risk on its accounts receivable, impacts on Hayward's business from political, regulatory, economic, trade, and other risks associated with operating international businesses, including risks associated with geopolitical conflict; its ability to maintain favorable relationships with suppliers and manage disruptions to its global supply chain and the availability of raw materials; Hayward's ability to identify emerging technological and other trends in its target end markets; failure of markets to accept new product introductions and enhancements; the ability to successfully identify, finance, complete and integrate acquisitions; its reliance on information technology systems and susceptibility to threats to those systems, including cybersecurity threats, and risks arising from its collection and use of personal information data; its use of artificial intelligence technologies may not be successful and may present business, intellectual property, compliance and reputational risks; misuse of its technology-enabled products could lead to reduced sales, liability claims or harm to its reputation; regulatory changes and developments affecting Hayward's current and future products; volatility in currency exchange rates and interest rates; Hayward's ability to service its existing indebtedness and obtain additional capital to finance operations and its growth opportunities; Hayward's ability to establish, maintain and effectively enforce intellectual property protection for its products, as well as its ability to operate its business without infringing, misappropriating or otherwise violating the intellectual property rights of others; the impact of material cost and other inflation, including as a result of new or increased tariffs; Hayward's ability to attract and retain senior management and other qualified personnel; the outcome of litigation and governmental proceedings; uncertainties related to distribution channel inventory practices and its impact on Hayward's net sales volumes; Hayward's ability to realize cost savings from restructuring activities and other factors set forth in "Risk Factors" in Hayward's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

Many of these factors are macroeconomic in nature and are, therefore, beyond Hayward's control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, Hayward's actual results, performance or achievements may vary materially from those described in this earnings release as anticipated, believed, estimated, expected, intended, planned or projected. The forward-looking statements included in this earnings release are made only as of the date of this earnings release. Unless required by United States federal securities laws, Hayward neither intends nor assumes any obligation to update these forward-looking statements for any reason after the date of this earnings release to conform these statements to actual results or to changes in Hayward's expectations.

*NON-GAAP FINANCIAL MEASURES

This earnings release includes certain financial measures not presented in accordance with the generally accepted accounting principles in the United States ("GAAP") including adjusted net income, adjusted basic EPS, adjusted diluted EPS, EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted segment income and adjusted segment income margin. These financial measures are not measures of financial performance in accordance with GAAP and may exclude items that are significant in understanding and assessing the Company's financial results. Hayward believes these non-GAAP measures provide analysts, investors and other interested parties with additional insight into the underlying trends of its business and assist these parties in analyzing the Company's performance across reporting periods on a consistent basis by excluding items that it does not believe are indicative of its core operating performance, which allows for a better comparison against historical results and expectations for future performance. Management uses these non-GAAP measures to understand and compare operating results across reporting periods for various purposes including internal budgeting and forecasting, short and long-term operating planning, employee incentive compensation, and debt compliance. These measures should not be considered in isolation or as an alternative to net income, segment income or other measures of profitability, performance or financial condition under GAAP. You should be aware that the Company's presentation of these measures may not be comparable to similarly titled measures used by other companies, which may be defined and calculated differently. See the appendix for a reconciliation of historical non-GAAP measures to the most directly comparable GAAP measures.

Reconciliation of full fiscal year 2025 adjusted EBITDA outlook to the comparable GAAP measure is not being provided, as Hayward does not currently have sufficient data to accurately estimate the variables and individual adjustments for such reconciliation. Adjusted EBITDA outlook for full year 2025 is calculated in a manner consistent with the historical presentation of this measure, as shown in the appendix.

Hayward Holdings, Inc.

Unaudited Condensed Consolidated Balance Sheets

(In thousands)

 
                              September 27, 2025     December 31, 2024 
                             --------------------  --------------------- 
Assets 
  Current assets 
    Cash and cash 
     equivalents              $          428,684    $         196,589 
    Short-term investments                19,650                   -- 
    Accounts receivable, 
     net of allowances of 
     $1,923 and $2,701, 
     respectively                        116,053              278,582 
    Inventories, net                     229,887              216,472 
    Prepaid expenses                      18,394               20,203 
    Income tax receivable                  2,548                6,426 
    Other current assets                  20,569               48,697 
                                 ---------------       -------------- 
    Total current assets                 835,785              766,969 
  Property, plant, and 
   equipment, net of 
   accumulated depreciation 
   of $121,814 and 
   $112,099, respectively                158,234              160,377 
  Goodwill                               949,952              943,645 
  Trademark                              736,000              736,000 
  Customer relationships, 
   net                                   183,296              198,333 
  Other intangibles, net                  88,274               96,095 
  Other non-current assets                84,079               89,205 
                                 ---------------       -------------- 
    Total assets              $        3,035,620    $       2,990,624 
                                 ===============       ============== 
Liabilities and 
Stockholders' Equity 
  Current liabilities 
    Current portion of 
     long-term debt           $           13,413    $          13,991 
    Accounts payable                      68,766               81,476 
    Accrued expenses and 
     other liabilities                   180,286              217,242 
    Income taxes payable                      --                  273 
                                 ---------------       -------------- 
    Total current 
     liabilities                         262,465              312,982 
  Long-term debt, net                    947,744              950,562 
  Deferred tax liabilities, 
   net                                   238,893              239,111 
  Other non-current 
   liabilities                            63,732               64,322 
                                 ---------------       -------------- 
    Total liabilities                  1,512,834            1,566,977 
 
Stockholders' equity 
  Preferred stock, $0.001 
  par value, 100,000,000 
  authorized, no shares 
  issued or outstanding as 
  of September 27, 2025 
  and December 31, 2024                       --                   -- 
  Common stock $0.001 par 
   value, 750,000,000 
   authorized; 245,717,477 
   issued and 217,051,108 
   outstanding at September 
   27, 2025; 244,444,889 
   issued and 215,778,520 
   outstanding at December 
   31, 2024                                  246                  245 
  Additional paid-in 
   capital                             1,105,018            1,093,468 
  Common stock in treasury; 
   28,666,369 and 
   28,666,369 at September 
   27, 2025 and December 
   31, 2024, respectively               (359,274)            (358,133) 
  Retained earnings                      782,724              699,564 
  Accumulated other 
   comprehensive income                   (5,928)             (11,497) 
                                 ---------------       -------------- 
    Total stockholders' 
     equity                            1,522,786            1,423,647 
                                 ---------------       -------------- 
    Total liabilities and 
     stockholders' equity     $        3,035,620    $       2,990,624 
                                 ===============       ============== 
 

Hayward Holdings, Inc.

Unaudited Condensed Consolidated Statements of Operations

(Dollars in thousands, except per share data)

 
                       Three Months Ended             Nine Months Ended 
                  ----------------------------  ------------------------------ 
                  September 27,  September 28,  September 27,   September 28, 
                      2025           2024           2025            2024 
                  -------------  -------------  -------------  --------------- 
Net sales         $    244,336   $    227,569   $    772,780   $    724,531 
Cost of sales          119,200        114,474        376,430        361,770 
                   -----------    -----------    -----------    ----------- 
  Gross profit         125,136        113,095        396,350        362,761 
Selling, general 
 and 
 administrative 
 expense                69,803         64,509        206,813        187,678 
Research, 
 development and 
 engineering 
 expense                 7,122          6,449         19,236         18,870 
Acquisition and 
 restructuring 
 related 
 expense                   276          1,145          3,767          2,488 
Amortization of 
 intangible 
 assets                  6,882          7,576         20,587         21,425 
                   -----------    -----------    -----------    ----------- 
  Operating 
   income               41,053         33,416        145,947        132,300 
                   -----------    -----------    -----------    ----------- 
Interest 
 expense, net           11,316         13,209         38,617         48,600 
Loss on debt 
 extinguishment             --             --             --          4,926 
Other expense 
 (income), net          (1,469)          (705)        (1,996)        (1,989) 
                   -----------    -----------    -----------    ----------- 
  Total other 
   expense               9,847         12,504         36,621         51,537 
                   -----------    -----------    -----------    ----------- 
Income from 
 operations 
 before income 
 taxes                  31,206         20,912        109,326         80,763 
Provision for 
 income taxes            7,178          4,411         26,166         16,841 
                   -----------    -----------    -----------    ----------- 
  Net income      $     24,028   $     16,501   $     83,160   $     63,922 
                   ===========    ===========    ===========    =========== 
 
Earnings per 
share 
  Basic           $       0.11   $       0.08   $       0.38   $       0.30 
  Diluted         $       0.11   $       0.07   $       0.37   $       0.29 
 
Weighted 
average common 
shares 
outstanding 
  Basic            216,826,626    215,231,886    216,395,032    214,836,643 
  Diluted          222,420,881    221,436,206    222,074,267    221,251,355 
 
 
                                          Nine Months Ended 
                            ---------------------------------------------- 
Hayward Holdings, Inc. 
Unaudited Condensed 
Consolidated Statements 
of Cash Flows (In 
thousands)                    September 27, 2025      September 28, 2024 
                            ----------------------  ---------------------- 
Cash flows from operating 
activities 
  Net income                 $          83,160       $           63,922 
  Adjustments to 
  reconcile net income to 
  net cash used in 
  operating activities 
    Depreciation                        17,026                   13,929 
    Amortization of 
     intangible assets                  25,808                   26,299 
    Amortization of 
     deferred debt 
     issuance fees                       2,818                    3,248 
    Stock-based 
     compensation                        9,821                    7,299 
    Deferred income taxes 
     (benefit)                           1,949                   (8,344) 
    Allowance for credit 
     losses                             (1,021)                     (62) 
    Loss on debt 
     extinguishment                         --                    4,926 
    (Gain) loss on sale of 
     property, plant and 
     equipment                             381                     (451) 
    Changes in operating 
    assets and 
    liabilities 
      Accounts receivable              168,754                  173,400 
      Inventories                       (8,064)                  (4,204) 
      Other current and 
       non-current assets               29,913                   (6,203) 
      Accounts payable                 (14,002)                   2,871 
      Accrued expenses and 
       other liabilities               (33,566)                    (868) 
                                --------------          --------------- 
Net cash provided by 
 operating activities                  282,977                  275,762 
                                --------------          --------------- 
 
Cash flows from investing 
activities 
    Purchases of property, 
     plant, and equipment              (19,822)                 (16,153) 
    Software development 
     costs                              (1,579)                  (1,399) 
    Acquisitions, net of 
     cash acquired                          --                  (61,636) 
    Proceeds from sale of 
     property, plant, and 
     equipment                              --                      311 
    Purchases of 
     short-term 
     investments                       (19,650)                      -- 
    Proceeds from 
     short-term 
     investments                            --                   25,000 
                                --------------          --------------- 
Net cash used in investing 
 activities                            (41,051)                 (53,877) 
                                --------------          --------------- 
 
Cash flows from financing 
activities 
    Proceeds from issuance 
     of long-term debt                      --                    2,886 
    Payments of long-term 
     debt                               (6,941)                (129,971) 
    Proceeds from issuance 
     of short-term notes 
     payable                                --                    6,340 
    Payments of short-term 
     notes payable                      (2,169)                  (4,676) 
    Debt issuance costs                 (1,388)                      -- 
    Purchase of common 
     stock                              (1,141)                      -- 
    Other, net                             719                     (427) 
                                --------------          --------------- 
Net cash used in financing 
 activities                            (10,920)                (125,848) 
                                --------------          --------------- 
 
Effect of exchange rate 
 changes on cash and cash 
 equivalents                             1,089                       50 
                                --------------          --------------- 
Change in cash and cash 
 equivalents                           232,095                   96,087 
Cash and cash equivalents, 
 beginning of period                   196,589                  178,097 
                                --------------          --------------- 
Cash and cash equivalents, 
 end of period               $         428,684       $          274,184 
                                ==============          =============== 
 
Supplemental disclosures 
of cash flow 
information: 
Cash paid-interest           $          39,892       $           47,965 
Cash paid-income taxes                  20,587                   26,853 
 
Non-cash investing and 
financing activities: 
Accrued and unpaid 
 purchases of property, 
 plant, and equipment                    1,064                    1,862 
Equipment financed under 
 finance leases                          1,866                      843 
 

Reconciliations

Consolidated Reconciliations

Adjusted EBITDA and Adjusted EBITDA Margin Reconciliations (Non-GAAP)

Following is a reconciliation from net income to adjusted EBITDA:

 
(Dollars in thousands)         Three Months Ended            Nine Months Ended 
                          ----------------------------  ---------------------------- 
                          September 27,  September 28,  September 27,  September 28, 
                              2025           2024           2025           2024 
                          -------------  -------------  -------------  ------------- 
Net income                $24,028        $16,501        $ 83,160       $ 63,922 
  Depreciation              5,509          4,862          17,026         13,929 
  Amortization              8,642          9,253          25,808         26,299 
  Interest expense, net    11,316         13,209          38,617         48,600 
  Income taxes              7,178          4,411          26,166         16,841 
  Loss on debt 
   extinguishment              --             --              --          4,926 
                           ------  ----   ------  ----   -------  ---   -------  --- 
    EBITDA                 56,673         48,236         190,777        174,517 
                           ------  ----   ------  ----   -------  ---   -------  --- 
  Stock-based 
   compensation (a)            --            136              57            556 
  Currency exchange 
   items (b)                 (536)          (344)            236           (470) 
  Acquisition and 
   restructuring related 
   expense, net (c)           276          1,145           3,767          2,488 
  Other (d)                 2,653          1,920           1,567          1,657 
                           ------  ----   ------  ----   -------  ---   -------  --- 
  Total Adjustments         2,393          2,857           5,627          4,231 
                           ------  ----   ------  ----   -------  ---   -------  --- 
    Adjusted EBITDA       $59,066        $51,093        $196,404       $178,748 
                           ======  ====   ======  ====   =======  ===   =======  === 
 
Net income margin             9.8%           7.3%           10.8%           8.8% 
Adjusted EBITDA margin       24.2%          22.5%           25.4%          24.7% 
 
 
(a)    Represents non-cash stock-based compensation expense related to equity 
       awards issued to management, employees, and directors. The adjustment 
       includes only expense related to awards issued under the 2017 Equity 
       Incentive Plan, which were awards granted prior to the effective date 
       of Hayward's initial public offering (the "IPO"). 
(b)    Represents unrealized non-cash (gains) losses on foreign denominated 
       monetary assets and liabilities and foreign currency contracts. 
(c)    Adjustments in the three months ended September 27, 2025 are primarily 
       driven by $0.3 million of costs related to restructuring actions in 
       E&RW. Adjustments in the three months ended September 28, 2024 are 
       primarily driven by $0.7 million of transaction and integration costs 
       associated with the acquisition of the ChlorKing business and $0.4 
       million of costs to finalize actions initiated in prior years. 
       Adjustments in the nine months ended September 27, 2025 are primarily 
       driven by $3.3 million of transaction and integration costs associated 
       with the acquisition of the ChlorKing business, $0.5 million of costs 
       related to restructuring actions in E&RW and $0.2 million of separation 
       costs for the consolidation of operations in North America, partially 
       offset by a reduction in expense of $0.2 million to finalize the 
       relocation of the Company's corporate office functions to Charlotte, 
       North Carolina from Berkeley Heights, New Jersey. Adjustments in the 
       nine months ended September 28, 2024 are primarily driven by $1.3 
       million of transaction and integration costs associated with the 
       acquisition of ChlorKing, $0.7 million of separation and other costs 
       associated with the centralization and consolidation of operations in 
       Europe and $0.4 million of costs to finalize actions initiated in prior 
       years. 
(d)    Adjustments in the three months ended September 27, 2025 primarily 
       include a $2.8 million non-recurring litigation expense. Expense beyond 
       the $2.8 million will be paid by the Company's insurance carriers 
       pursuant to the Company's retention amount with its insurance carriers. 
       Other adjustments include $0.2 million of income from insurance 
       proceeds related to flood damage associated with a hurricane at a 
       contract manufacturing facility. Adjustments in the three months ended 
       September 28, 2024 are primarily driven by a $1.6 million non-cash 
       increase in cost of goods sold resulting from the fair value inventory 
       step-up adjustment recognized as part of the purchase accounting for 
       the acquisition of the ChlorKing business and $0.3 million of costs 
       incurred related to litigation. Adjustments in the nine months ended 
       September 27, 2025 primarily include a $2.8 million non-recurring 
       litigation expense. Expense beyond the $2.8 million will be paid by the 
       Company's insurance carriers pursuant to the Company's retention amount 
       with its insurance carriers. Other adjustments include $1.3 million of 
       income from insurance proceeds related to flood damage associated with 
       a hurricane at a contract manufacturing facility. Adjustments in the 
       nine months ended September 28, 2024 are primarily driven by a $1.6 
       million non-cash increase in cost of goods sold resulting from the fair 
       value inventory step-up adjustment recognized as part of the purchase 
       accounting for the acquisition of the ChlorKing business and $0.5 
       million of costs incurred related to litigation, partially offset by 
       $0.5 million of gains on the sale of assets. 
 

Following is a reconciliation from net income to adjusted EBITDA for the last twelve months:

 
(Dollars in thousands)      Last Twelve Months(e)         Fiscal Year 
                          -------------------------  --------------------- 
                             September 27, 2025        December 31, 2024 
                          -------------------------  --------------------- 
Net income                  $         137,893         $       118,655 
Depreciation                           23,175                  20,078 
Amortization                           35,292                  35,783 
Interest expense, net                  52,180                  62,163 
  Income taxes                         34,852                  25,527 
  Loss on debt 
   extinguishment                          --                   4,926 
                          ---  --------------  ----      ------------  --- 
    EBITDA                            283,392                 267,132 
  Stock-based 
   compensation (a)                       109                     608 
  Currency exchange 
   items (b)                             (130)                   (836) 
  Acquisition and 
   restructuring related 
   expense, net (c)                     7,743                   6,464 
  Other (d)                             3,989                   4,079 
                          ---  --------------  ----      ------------  --- 
  Total Adjustments                    11,711                  10,315 
                          ---  --------------  ----      ------------  --- 
    Adjusted EBITDA         $         295,103         $       277,447 
                          ===  ==============  ====      ============  === 
 
Net income margin                        12.5%                   11.3% 
Adjusted EBITDA margin                   26.8%                   26.4% 
 
 
(a)    Represents non-cash stock-based compensation expense related to equity 
       awards issued to management, employees, and directors. The adjustment 
       includes only expense related to awards issued under the 2017 Equity 
       Incentive Plan, which were awards granted prior to the effective date 
       of the IPO. 
(b)    Represents unrealized non-cash (gains) losses on foreign denominated 
       monetary assets and liabilities and foreign currency contracts. 
(c)    Adjustments in the last twelve months ended September 27, 2025 
       primarily include $6.3 million of compensation expenses for the 
       retention of key employees acquired in the ChlorKing acquisition. 
       Pursuant to the ChlorKing acquisition agreement, this $6.3 million was 
       an employee retention payment that was deposited into an escrow account 
       on the date of acquisition. The full amount held in escrow was to be 
       released to the specified key employees if such employees are employed 
       by Hayward on the one-year anniversary of the acquisition. These 
       payments were contingent on continued employment and are not dependent 
       on the achievement of any metric or performance measure. The retention 
       costs were recognized over the twelve-month period from the date of 
       acquisition. Further, other adjustments include $1.1 million of 
       termination benefits related to a reduction-in-force within E&RW, $0.3 
       million of facility and other costs related to a restructuring action 
       within E&RW and $0.2 million of separation costs associated with the 
       consolidation of operations in North America, partially offset by a 
       reduction in expense of $0.2 million to finalize the relocation of the 
       Company's corporate headquarters to Charlotte, North Carolina. 
       Adjustments in the year ended December 31, 2024 are primarily driven by 
       $3.2 million of compensation expenses for the retention of key 
       employees acquired in the ChlorKing acquisition. Pursuant to the 
       ChlorKing acquisition agreement, this $3.2 million was part of a total 
       $6.3 million employee retention payment that was deposited into an 
       escrow account on the date of acquisition. The full amount held in 
       escrow will be released to the specified key employees if such 
       employees are employed by Hayward on the one-year anniversary of the 
       acquisition. These payments are contingent on continued employment and 
       are not dependent on the achievement of any metric or performance 
       measure. The retention costs will be recognized over the twelve-month 
       period from the date of acquisition. Further, other adjustments for the 
       year ended December 31, 2024 include $1.1 million of transaction and 
       integration costs associated with the acquisition of the ChlorKing 
       business, $0.9 million of termination benefits related to a 
       reduction-in-force within E&RW, $0.8 million of separation and other 
       costs associated with the centralization and consolidation of 
       operations in Europe and $0.4 million of costs to finalize 
       restructuring actions initiated in prior years. 
(d)    Adjustments in the last twelve months ended September 27, 2025 are 
       primarily driven by a $2.8 million non-recurring litigation expense, a 
       $1.6 million increase in cost of goods sold resulting from the fair 
       value inventory step-up adjustment recognized as part of the purchase 
       accounting for the acquisition of the ChlorKing business partially 
       offset by $0.6 million of net insurance settlement proceeds which 
       reflects costs incurred of $0.7 million offset by $1.3 million of 
       insurance proceeds related to flood damage associated with a hurricane 
       at a contract manufacturing facility. Adjustments in the year ended 
       December 31, 2024 are primarily driven by a $3.3 million increase in 
       cost of goods sold resulting from the fair value inventory step-up 
       adjustment recognized as part of the purchase accounting for the 
       acquisition of the ChlorKing business, $0.7 million of costs sustained 
       from flood damage associated with a hurricane at a contract 
       manufacturing facility and $0.5 million of costs incurred related to 
       litigation, partially offset by $0.5 million of gains on the sale of 
       assets. 
(e)    Items for the last twelve months ended September 27, 2025 are 
       calculated by adding the items for the nine months ended September 27, 
       2025 plus fiscal year ended December 31, 2024 and subtracting the items 
       for the nine months ended September 28, 2024. 
 

Adjusted Net Income and Adjusted EPS Reconciliation (Non-GAAP)

Following is a reconciliation of net income to adjusted net income and earnings per share to adjusted earnings per share:

 
(Dollars in thousands, 
except per share data)         Three Months Ended             Nine Months Ended 
                          ----------------------------  ------------------------------ 
                          September 27,  September 28,  September 27,   September 28, 
                              2025           2024           2025            2024 
                          -------------  -------------  -------------  --------------- 
Net income                $     24,028   $     16,501   $     83,160   $     63,922 
Tax adjustments (a)               (481)          (451)          (673)        (2,203) 
Other adjustments and 
amortization: 
    Stock-based 
     compensation (b)               --            136             57            556 
    Currency exchange 
     items (c)                    (536)          (344)           236           (470) 
    Acquisition and 
     restructuring 
     related expense, 
     net (d)                       276          1,145          3,767          2,488 
    Other (e)                    2,653          1,920          1,567          1,657 
                           -----------    -----------    -----------    ----------- 
  Total other 
   adjustments                   2,393          2,857          5,627          4,231 
Loss on debt 
 extinguishment                     --             --             --          4,926 
Amortization                     8,642          9,253         25,808         26,299 
Tax effect (f)                  (2,708)        (2,815)        (7,717)        (8,360) 
                           -----------    -----------    -----------    ----------- 
Adjusted net income       $     31,874   $     25,345   $    106,205   $     88,815 
                           ===========    ===========    ===========    =========== 
 
Weighted average number 
 of common shares 
 outstanding, basic        216,826,626    215,231,886    216,395,032    214,836,643 
Weighted average number 
 of common shares 
 outstanding, diluted      222,420,881    221,436,206    222,074,267    221,251,355 
 
Basic EPS                 $       0.11   $       0.08   $       0.38   $       0.30 
Diluted EPS               $       0.11   $       0.07   $       0.37   $       0.29 
 
Adjusted basic EPS        $       0.15   $       0.12   $       0.49   $       0.41 
Adjusted diluted EPS      $       0.14   $       0.11   $       0.48   $       0.40 
 
 
(a)    Tax adjustments for the three and nine months ended September 27, 2025 
       reflect a normalized tax rate of 24.5% and 24.5%, respectively, 
       compared to the Company's effective tax rate of 23.0% and 23.9%, 
       respectively. The Company's effective tax rate for the three and nine 
       months ended September 27, 2025 primarily includes the tax benefits 
       resulting from stock compensation. Tax adjustments for the three and 
       nine months ended September 28, 2024 reflect a normalized tax rate of 
       23.2% and 22.5%, respectively, compared to the Company's effective tax 
       rate of 21.1% and 20.9%, respectively. The Company's effective tax rate 
       for the three months ended September 28, 2024 includes the tax benefits 
       resulting from stock compensation and the nine months ended September 
       28, 2024 additionally includes a tax benefit resulting from a 
       return-to-provision adjustment. 
(b)    Represents non-cash stock-based compensation expense related to equity 
       awards issued to management, employees, and directors. The adjustment 
       includes only expense related to awards issued under the 2017 Equity 
       Incentive Plan, which were awards granted prior to the effective date 
       of the IPO. 
(c)    Represents unrealized non-cash (gains) losses on foreign denominated 
       monetary assets and liabilities and foreign currency contracts. 
(d)    Adjustments in the three months ended September 27, 2025 are primarily 
       driven by $0.3 million of costs related to restructuring actions in 
       E&RW. Adjustments in the three months ended September 28, 2024 are 
       primarily driven by $0.7 million of transaction and integration costs 
       associated with the acquisition of the ChlorKing business and $0.4 
       million of costs to finalize actions initiated in prior years. 
       Adjustments in the nine months ended September 27, 2025 are primarily 
       driven by $3.3 million of transaction and integration costs associated 
       with the acquisition of the ChlorKing business, $0.5 million of costs 
       related to restructuring actions in E&RW and $0.2 million of separation 
       costs for the consolidation of operations in North America, partially 
       offset by a reduction in expense of $0.2 million to finalize the 
       relocation of the Company's corporate office functions to Charlotte, 
       North Carolina from Berkeley Heights, New Jersey. Adjustments in the 
       nine months ended September 28, 2024 are primarily driven by $1.3 
       million of transaction and integration costs associated with the 
       acquisition of ChlorKing, $0.7 million of separation and other costs 
       associated with the centralization and consolidation of operations in 
       Europe and $0.4 million of costs to finalize actions initiated in prior 
       years. 
(e)    Adjustments in the three months ended September 27, 2025 primarily 
       include a $2.8 million non-recurring litigation expense. Expense beyond 
       the $2.8 million will be paid by the Company's insurance carriers 
       pursuant to the Company's retention amount with its insurance carriers. 
       Other adjustments include $0.2 million of income from insurance 
       proceeds related to flood damage associated with a hurricane at a 
       contract manufacturing facility. Adjustments in the three months ended 
       September 28, 2024 are primarily driven by a $1.6 million non-cash 
       increase in cost of goods sold resulting from the fair value inventory 
       step-up adjustment recognized as part of the purchase accounting for 
       the acquisition of the ChlorKing business and $0.3 million of costs 
       incurred related to litigation. Adjustments in the nine months ended 
       September 27, 2025 primarily include a $2.8 million non-recurring 
       litigation expense. Expense beyond the $2.8 million will be paid by the 
       Company's insurance carriers pursuant to the Company's retention amount 
       with its insurance carriers. Other adjustments include $1.3 million of 
       income from insurance proceeds related to flood damage associated with 
       a hurricane at a contract manufacturing facility. Adjustments in the 
       nine months ended September 28, 2024 are primarily driven by a $1.6 
       million non-cash increase in cost of goods sold resulting from the fair 
       value inventory step-up adjustment recognized as part of the purchase 
       accounting for the acquisition of the ChlorKing business and $0.5 
       million of costs incurred related to litigation, partially offset by 
       $0.5 million of gains on the sale of assets. 
(f)    The tax effect represents the immediately preceding adjustments at the 
       normalized tax rates as discussed in footnote (a) above. 
 

Segment Reconciliations

Following is a reconciliation from segment income to adjusted segment income for the North America ("NAM") and Europe & Rest of World ("E&RW") segments:

 
(Dollars in thousands)      Three Months Ended       Three Months Ended 
                          -----------------------  ----------------------- 
                            September 27, 2025       September 28, 2024 
                          -----------------------  ----------------------- 
                              NAM         E&RW         NAM         E&RW 
                          -----------  ----------  -----------  ---------- 
Segment income            $55,387      $6,247      $51,569      $2,475 
  Depreciation              4,675         441        4,404         271 
  Amortization              1,760          --        1,677          -- 
  Stock-based 
  compensation                 --          --          107          -- 
  Other (a)                  (101)         --        1,704          -- 
                           ------       -----       ------       ----- 
    Total adjustments       6,334         441        7,892         271 
                           ------       -----       ------       ----- 
Adjusted segment income   $61,721      $6,688      $59,461      $2,746 
                           ======       =====       ======       ===== 
 
  Segment income margin 
   %                         26.6%       17.3%        26.4%        7.6% 
  Adjusted segment 
   income margin %           29.6%       18.5%        30.5%        8.4% 
 
 
(a)    The three months ended September 27, 2025 includes $0.1 million of 
       insurance proceeds related to flood damage associated with a hurricane 
       at a contract manufacturing facility. The three months ended September 
       28, 2024 primarily includes a $1.6 million non-cash increase in cost of 
       goods sold resulting from the fair value inventory step-up adjustment 
       recognized as part of the purchase accounting for the acquisition of 
       the ChlorKing business. 
 
 
 
(Dollars in thousands)       Nine Months Ended           Nine Months Ended 
                         --------------------------  ------------------------- 
                             September 27, 2025         September 28, 2024 
                         --------------------------  ------------------------- 
                              NAM          E&RW          NAM          E&RW 
                          ------------  -----------  ------------  ----------- 
Segment income            $182,215      $20,374      $166,646      $16,800 
  Depreciation              14,623        1,294        12,619          791 
  Amortization               5,221           --         4,874           -- 
  Stock-based 
   compensation                 --           --           176           10 
  Other (a)                   (611)          --         1,723           -- 
                           -------       ------       -------       ------ 
    Total adjustments       19,233        1,294        19,392          801 
                           -------       ------       -------       ------ 
Adjusted segment income   $201,448      $21,668      $186,038      $17,601 
                           =======       ======       =======       ====== 
 
  Segment income margin 
   %                          28.0%        16.7%         27.3%        14.6% 
  Adjusted segment 
   income margin %            31.0%        17.7%         30.5%        15.3% 
 
 
(a)    The nine months ended September 27, 2025 primarily includes $0.6 
       million of insurance proceeds related to flood damage associated with a 
       hurricane at a contract manufacturing facility. The nine months ended 
       September 28, 2024 primarily includes a $1.6 million non-cash increase 
       in cost of goods sold resulting from the fair value inventory step-up 
       adjustment recognized as part of the purchase accounting for the 
       acquisition of the ChlorKing business. 
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20251029671591/en/

 
    CONTACT:    Investor Relations: 

Kevin Maczka

investor.relations@hayward.com

Media Relations:

Misty Zelent

mzelent@hayward.com

 
 

(END) Dow Jones Newswires

October 29, 2025 07:01 ET (11:01 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment